Grand Pharmaceutical Group Limited (HKG:0512)
6.09
-0.07 (-1.14%)
May 12, 2026, 4:08 PM HKT
HKG:0512 Market Cap
HKG:0512 has a market cap or net worth of 21.57 billion as of May 11, 2026. Its market cap has increased by 6.21% in one year.
Market Cap
21.57B
Enterprise Value
22.53B
Revenue
12.28B
Ranking
n/a
PE Ratio
17.38
Stock Price
6.09
Market Cap Chart
Since February 28, 1996, HKG:0512's market cap has increased from 1.42B to 21.57B, an increase of 1,414.86%. That is a compound annual growth rate of 9.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 21.54B | -21.66% |
| Dec 31, 2025 | 27.49B | 63.54% |
| Dec 31, 2024 | 16.81B | 16.78% |
| Dec 29, 2023 | 14.39B | -11.29% |
| Dec 30, 2022 | 16.22B | -29.24% |
| Dec 31, 2021 | 22.93B | -6.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Pharmaceutical Group | 32.35B |
| Simcere Pharmaceutical Group | 30.86B |
| China Medical System Holdings | 29.80B |
| Sunshine Lake Pharma | 24.40B |
| The United Laboratories International Holdings | 19.53B |
| Fujian Haixi Pharmaceuticals | 18.57B |
| Consun Pharmaceutical Group | 12.87B |
| CanSino Biologics | 12.34B |